How many employees work at Biobot Surgical?
Biobot Surgical Pte Ltd. has approximately 87 total employees worldwide as of March 2026, according to Revelio Labs workforce intelligence data. Biobot Surgical’s total headcount has grown 64.0% from 53 employees in 2023 to 87 in 2026.
Is Biobot Surgical hiring right now?
Yes, Biobot Surgical is actively hiring. Biobot Surgical had 1 active job postings in 2026, a 200.0% increase from 2025 — see job openings & hiring trends.
About Biobot Surgical’s Workforce
Biobot Surgical Pte Ltd. is a Biotech and Healthcare Services company that employs 87 people worldwide as of March 2026. It is the 2nd-largest by headcount among its peers. Founded in 2007, the company is headquartered in Cameroon.
Biobot Surgical's workforce has grown 64.0% from 2023 to 2026, though it is down 0.4% year over year in 2026. It fell to a low of 52 in 2023 Q3 before recovering. Its workforce is concentrated most in Southeast Asia (86.1%), followed by North America (8.8%) and Northern Europe (5.0%).
Biobot Surgical's functional groups are Finance and Operations (39.4%), Engineering (33.2%), and Sales and Marketing (27.3%), with Engineering growing fastest (up 13.4%). The average salary is $84,639, ranging from a median of $88,000 in North America to $61,000 in Southeast Asia, up 4.4% year over year in 2026.
Biobot Surgical's active job postings rose 200.0% in 2026 to 1.
Sourced from Revelio Labs workforce data.
- Headquarters
- Cameroon
- Founded
- 2007
- Industry
- Biotech and Healthcare Services
- Employees
- 87
- YoY
- -0.4% (+9)
As of March 2026
Biobot Surgical workforce metrics
Unlock hiring rate, attrition rate, and 12 additional workforce metrics for Biobot Surgical. Compare to peers, export the dataset, and access the full quarterly history.
Unlock MetricsBiobot Surgical Annual Employee Count (2023-2026)
- Biobot Surgical had 87 employees in 2026, a 0.4% decline (+9) from 2025.
- Biobot Surgical had 83 employees in 2025, a 11.1% decline from 2024.
- Biobot Surgical had 83 employees in 2024, a 36.2% increase (+27) from 2023.
- Biobot Surgical had 56 employees in 2023, a 2.9% increase (+16) from 2022.
Biobot Surgical's total workforce has grown from 53 employees in 2023 to 87 in 2026.
Biobot Surgical Pte Ltd. quarterly employee count
| Year | Qtr | Employees | YoY Change | YoY % |
|---|---|---|---|---|
| 2026 | Q1 | 87 | +9 | -0.4% |
| 2025 | Q4 | 83 | +0 | -11.1% |
| 2025 | Q3 | 79 | +0 | -5.7% |
| 2025 | Q2 | 82 | +10 | +1.1% |
| 2025 | Q1 | 78 | +18 | +18.2% |
| 2024 | Q4 | 83 | +27 | +36.2% |
| 2024 | Q3 | 79 | +27 | +33.2% |
| 2024 | Q2 | 72 | +19 | +21.5% |
| 2024 | Q1 | 60 | +19 | +9.9% |
| 2023 | Q4 | 56 | +16 | +2.9% |
| 2023 | Q3 | 52 | +11 | -2.1% |
| 2023 | Q2 | 53 | +11 | +1.5% |
See Biobot Surgical's complete headcount history, including quarterly breakdowns.
Get the DataBiobot Surgical Employee Count by Region (2026)
Southeast Asia accounts for the largest share of Biobot Surgical's global workforce with approximately 86% of total employees, followed by North America and Northern Europe.
Biobot Surgical employees by region
| Region | Employees | % of Total |
|---|---|---|
| Southeast Asia | 70 | 86.1% |
| North America | 7 | 8.8% |
| Northern Europe | 4 | 5.0% |
Drill into city-level data, hiring trends by region, and historic geographic shifts.
Unlock Geographic DataBiobot Surgical Employee Count by Department (2026)
Biobot Surgical's employee groups are Finance and Operations (39.4%), Engineering (33.2%), and Sales and Marketing (27.3%).
Biobot Surgical employees by department
| Department | Employees | % of Total |
|---|---|---|
| Finance and Operations | 34 | 39.4% |
| Engineering | 29 | 33.2% |
| Sales and Marketing | 24 | 27.3% |
Compare Biobot Surgical's department mix to industry peers.
See Full DataBiobot Surgical Employee Salary by Region (2026)
Biobot Surgical's average employee salary is $84,639 globally. Employees in North America receive the highest compensation. Pay is lowest in Southeast Asia, at a median of $61,000.
Biobot Surgical median employee salary by region (USD)
| Region | Median Salary |
|---|---|
| North America | $88,000 |
| Southeast Asia | $61,000 |
Unlock salary by role, level, and city — and compare to Biobot Surgical's industry peers.
Unlock Salary DataBiobot Surgical Job Openings and Hiring Trends (2023-2026)
- Biobot Surgical had 1 active job postings in 2026, a 200.0% increase (+1) from 2025.
- Biobot Surgical had 0 active job postings in 2025, a 200.0% decline (-4) from 2024.
- Biobot Surgical had 4 active job postings in 2024, a 200.0% increase (+4) from 2023.
- Biobot Surgical had 0 active job postings in 2023, a 200.0% decline from 2022.
- Hiring velocity in 2026: 0 new roles/month, down from 1 in 2025 and 1 in 2024.
Biobot Surgical's active job postings rose 200.0% in 2026 to 1.
Track new postings per month, role-level demand, and hiring velocity vs. peers.
Unlock Hiring DataSimilar Companies
Similar Biotech and Healthcare Services Companies by Employee Count
Frequently Asked Questions About Biobot Surgical
- How fast is Biobot Surgical growing?
- In 2026, Biobot Surgical's headcount shrank 0.4% to 87 employees, up from 78 in 2025.
- See the full headcount history
- Where are Biobot Surgical employees located?
- Most Biobot Surgical employees are based in Southeast Asia (86.1% of headcount), followed by North America and Northern Europe.
- Explore where the workforce is based
- What is the average salary at Biobot Surgical?
- The average employee salary at Biobot Surgical is approximately $84.6k per year.
- Analyze the salary distribution
- How many new job postings does Biobot Surgical open per year?
- In Q1 2026, Biobot Surgical opened 1 new job postings. In 2025, Biobot Surgical opened 13 new job postings — about 1 per month.
- Track hiring trends by role
- When was Biobot Surgical founded and where is it headquartered?
- Biobot Surgical was founded in 2007 and is headquartered in Cameroon.
- Compare Biobot Surgical to industry peers
Speak with a workforce expert about Biobot Surgical.
Book a DemoSee something that doesn't look right? Reach out and our team will review it.